Antimycobacterial and synergistic effects of 18β-glycyrrhetinic acid or glycyrrhetinic acid-30-piperazine in combination with isoniazid, rifampicin or streptomycin against Mycobacterium bovis

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 253-258

  Zhou, Xuezhang ^a   Zhao, Li ^a   Liu, Xiaoming ^a   Li, Xueqiang ^a   Jia, Fang ^a   Zhang, Yuyan ^a   Wang, Yujiong ^a  

^a NINGXIA UNIVERSITY   (China)

Author keywords

18 glycyrrhetinic acid; antimycobacterial agents; glycyrrhetinic acid 30 piperazine; Mycobacterium bovis; Mycobacterium tuberculosis; natural compound

Indexed keywords

GLYCYRRHETINIC ACID; GLYCYRRHETINIC ACID 30 PIPERAZINE; GLYCYRRHETINIC ACID DERIVATIVE; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CANCER CELL CULTURE; CELL STRAIN BHK; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG RESEARCH; DRUG SENSITIVITY; FRACTIONAL INHIBITORY CONCENTRATION INDEX; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM BOVIS; NONHUMAN; PHARMACOLOGICAL PARAMETERS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; GLYCYRRHETINIC ACID; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; PIPERAZINES; RIFAMPIN; STREPTOMYCIN;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84856303235     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3536     Document Type: Article

References (25)

1. Adhvaryu MR, Reddy N, Vakharia BC,. 2008. Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach. World J Gastroenterol 14: 4753-4762.
2. Baker DD, Chu M, Oza U, Rajgarhia V,. 2007. The value of natural products to future pharmaceutical discovery. Nat Prod Rep 24: 1225-1244. (Pubitemid 350151353)
3. Besser RE, Pakiz B, Schulte JM, et al,. 2001. Risk factors for positive mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics 108: 305-310.
4. Cha JD, Moon SE, Kim JY, Jung EK, Lee YS,. 2009. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus. Phytother Res 23: 1326-1331.
5. Dai HF, Gan YJ, Que DM, Wu J, Wen ZC, Mei WL,. 2009. A new cytotoxic 19-nor-cardenolide from the latex of Antiaris toxicaria. Molecules 14: 3694-3699.
6. Darwish RM, Aburjai TA,. 2010. Effect of ethnomedicinal plants used in folklore medicine in Jordan as antibiotic resistant inhibitors on Escherichia coli. BMC Complement Altern Med 10: 9.
7. Eltringham IJ, Drobniewski FA, Mangan JA, Butcher PD, Wilson SM,. 1999. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 37: 3524-3527. (Pubitemid 29491086)
8. Evans JT, Smith EG, Banerjee A, et al,. 2007. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet 369: 1270-1276. (Pubitemid 46552049)
9. Franzblau SG, Witzig RS, McLaughlin JC, et al,. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36: 362-366. (Pubitemid 28060296)
10. Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J,. 2003. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytother Res 17: 903-908. (Pubitemid 37152755)
11. LoBue PA, Betacourt W, Peter C, Moser KS,. 2003. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000. Int J Tuberc Lung Dis 7: 180-185. (Pubitemid 36172680)
12. Loske C, Neumann A, Cunningham AM, et al,. 1998. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105: 1005-1015. (Pubitemid 28539843)
13. Maatooq GT, Marzouk AM, Gray AI, Rosazza JP,. 2010. Bioactive microbial metabolites from glycyrrhetinic acid. Phytochemistry 71: 262-270.
14. Mishra KC, de Chastellier C, Narayana Y, et al,. 2008. Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY. Infect Immun 76: 127-140.
15. Nabekura T, Yamaki T, Kitagawa S,. 2008a. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. Eur J Pharmacol 600: 45-49.
16. Nabekura T, Yamaki T, Ueno K, Kitagawa S,. 2008b. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 62: 867-873.
17. Park WB, Kim W, Lee KL, et al,. 2010. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis. J Infect 61: 323-329.
18. Pellati D, Fiore C, Armanini D, Rassu M, Bertoloni G,. 2009. In vitro effects of glycyrrhetinic acid on the growth of clinical isolates of Candida albicans. Phytother Res 23: 572-574.
19. Petersen PJ, Labthavikul P, Jones CH, Bradford PA,. 2006. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57: 573-576. (Pubitemid 43240214)
20. Smith I., 2003. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16: 463-496. (Pubitemid 36871317)
21. Spinks EA, Fenwick GR,. 1990. The determination of glycyrrhizin in selected UK liquorice products. Food Addit Contam 7: 769-778.
22. Tanaka Y, Kikuzaki H, Fukuda S, Nakatani N,. 2001. Antibacterial compounds of licorice against upper airway respiratory tract pathogens. J Nutr Sci Vitaminol (Tokyo) 47: 270-273. (Pubitemid 32785840)
23. Wilson SM, al-Suwaidi Z, McNerney R, Porter J, Drobniewski F,. 1997. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med 3: 465-468. (Pubitemid 27145692)
24. Wu X, Zhang L, Gurley E, et al,. 2008. Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology 47: 1905-1915. (Pubitemid 351945558)
25. Xiao Y, Xu J, Mao C, et al,. 2010. 18Beta-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha. J Biol Chem 285: 1128-1137.